MELANY's data-driven read on Intuitive Surgical Inc. · Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Intuitive develops, manufactures, and markets a robotic system that assists minimally invasive surgery, and also supplies the related instruments, disposable accessories, and warranty services. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, including more than 6,000 in the US and a growing number in emerging markets.
MELANY scores Intuitive Surgical Inc. 55/100 by weighing eight factors. Here is how ISRG breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
History of beating or missing estimates, and where estimates are heading.
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Intuitive Surgical Inc. sits in the Robotics + AI theme, which MELANY currently rates 15/100 for strength. Theme strength feeds ISRG's momentum and catalyst factors above.
Intuitive Surgical Inc. rates Hold right now, so MELANY is not flagging a fresh entry. Create a free account to add ISRG to your watchlist and get alerted the moment the rating changes.
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Intuitive Surgical Inc.'s 55/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
As of 2026-08-20, MELANY rated Intuitive Surgical Inc. Hold with a composite score of 55/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
Intuitive Surgical Inc. (ISRG) has a MELANY composite score of 55/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, and macro fit.
MELANY scores ISRG from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Intuitive Surgical Inc. (ISRG) Hold with a composite of 55/100 as of 2026-08-20. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
MELANY does not publish price targets or forecasts for ISRG. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 55/100 across eight factors for Intuitive Surgical Inc., and re-scores automatically as new price, earnings, and fundamental data arrive.
MELANY's valuation factor currently reads 27/100 for Intuitive Surgical Inc., where a higher score means the price looks more attractive against earnings, growth, and peers. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives ISRG's read.
MELANY is not flagging a fresh entry for ISRG at its current Hold rating, so there is no entry zone to publish right now. Watchlisting ISRG in the free app gets you alerted the moment that changes.
The top risks MELANY currently flags for Intuitive Surgical Inc.: Weak price momentum, trend not yet confirmed, may need more time to set up. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
For long-term durability the two factors that matter most are business quality, which MELANY scores 77/100 for Intuitive Surgical Inc., and earnings track record, at 98/100. The 55/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 29/100 for ISRG right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
The rating on this page is a snapshot of MELANY's read as of 2026-08-20. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores ISRG continuously as new price, earnings, and fundamental data arrive, and that current rating is free in the app.
ISRG's live rating and alerts are free either way. The app is our flagship.